Divergent Planning LLC Acquires New Position in Danaher Corporation $DHR

Divergent Planning LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 2,281 shares of the conglomerate’s stock, valued at approximately $451,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. GAMMA Investing LLC raised its holdings in Danaher by 22.2% in the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after acquiring an additional 1,660 shares in the last quarter. Pacific Capital Partners Ltd purchased a new stake in shares of Danaher in the 1st quarter valued at approximately $7,175,000. Live Oak Private Wealth LLC raised its holdings in shares of Danaher by 3.9% in the 1st quarter. Live Oak Private Wealth LLC now owns 45,506 shares of the conglomerate’s stock valued at $9,329,000 after purchasing an additional 1,717 shares in the last quarter. Flagship Harbor Advisors LLC lifted its position in shares of Danaher by 13.7% during the 1st quarter. Flagship Harbor Advisors LLC now owns 10,149 shares of the conglomerate’s stock worth $2,081,000 after purchasing an additional 1,221 shares during the last quarter. Finally, Sawgrass Asset Management LLC grew its stake in shares of Danaher by 22.2% during the first quarter. Sawgrass Asset Management LLC now owns 65,643 shares of the conglomerate’s stock worth $13,457,000 after purchasing an additional 11,924 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.20% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on DHR. Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 target price (down previously from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Wells Fargo & Company lowered their price target on Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a report on Wednesday, July 23rd. UBS Group dropped their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Finally, Barclays restated an “overweight” rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Seventeen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $245.00.

Danaher Trading Down 0.5%

Shares of Danaher stock opened at $208.06 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company has a market capitalization of $148.98 billion, a P/E ratio of 44.27, a PEG ratio of 2.98 and a beta of 0.77. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $274.21. The company’s fifty day moving average is $201.76 and its two-hundred day moving average is $197.42.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the prior year, the firm earned $1.72 earnings per share. The business’s quarterly revenue was up 3.4% compared to the same quarter last year. Analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.